首页> 外文期刊>AJOB empirical bioethics. >A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey
【24h】

A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey

机译:药物生命伦理学咨询服务:六年描述性特征和反馈调查的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Bioethics consultations are conducted in varied settings, including hospitals, universities, and other research institutions, but there is sparse information about bioethics consultations conducted in corporate settings such as pharmaceutical companies. The purpose of this article is to describe a bioethics consultation service at a pharmaceutical company, to report characteristics of consultations completed by the service over a 6-year period, and to share results of a consultation feedback survey. Methods: Data on the descriptive characteristics of bioethics consultations were collected from 2008 to 2013 and analyzed in Excel 2007. Categorical data were analyzed via the pivot table function, and time-based variables were analyzed via formulas. The feedback survey was administered to consultation requesters from 2009 to 2012 and also analyzed in Excel 2007. Results: Over the 6-year period, 189 bioethics consultations were conducted. The number of consultations increased from five per year in 2008 to approximately one per week in 2013. During this time, the format of the consultation service was changed from a committee-only approach to a tiered approach (tailored to the needs of the case). The five most frequent topics were informed consent, early termination of a clinical trial, benefits and risks, human biological samples, and patient rights. The feedback survey results suggest the consultation service is well regarded overall and viewed as approachable, helpful, and responsive. Conclusions: Pharmaceutical bioethics consultation is a unique category of bioethics consultation that primarily focuses on pharmaceutical research and development but also touches on aspects of clinical ethics, business ethics, and organizational ethics. Results indicate there is a demand for a tiered bioethics consultation service within this pharmaceutical company and that advice was valued. This company's experience indicates that a bioethics consultation service raises awareness about bioethics, empowers employees to raise bioethical concerns, and helps them reason through challenging issues.
机译:背景:生物伦理学咨询是在包括医院,大学和其他研究机构在内的各种环境中进行的,但是在诸如制药公司等公司环境中进行的生物伦理学咨询的信息很少。本文的目的是描述一家制药公司的生物伦理咨询服务,报告该服务在6年内完成的咨询的特征,并共享咨询反馈调查的结果。方法:收集2008年至2013年有关生物伦理咨询的描述性数据,并在Excel 2007中进行分析。通过数据透视表功能对分类数据进行分析,并通过公式对基于时间的变量进行分析。反馈调查于2009年至2012年对咨询者进行了管理,并在Excel 2007中进行了分析。结果:在6年的时间里,进行了189次生物伦理学咨询。咨询次数从2008年的每年5次增加到2013年的每周大约1次。在此期间,咨询服务的形式已从仅委员会的方式变为分层的方式(根据案件的需要而定) 。五个最常见的主题是知情同意,临床试验的提前终止,收益和风险,人体生物样本以及患者权利。反馈调查结果表明,咨询服务总体上被认为是平易近人的,有用的和响应迅速的。结论:药物生物伦理学咨询是生物伦理学咨询的独特类别,其主要侧重于药物研发,但也涉及临床伦理学,商业伦理学和组织伦理学的各个方面。结果表明,该制药公司需要分层的生物伦理咨询服务,并且该建议很有价值。该公司的经验表明,生物伦理咨询服务可以提高人们对生物伦理​​的认识,使员工有能力提出生物伦理问题,并帮助他们通过具有挑战性的问题进行推理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号